Mobileye Global Inc. (MBLY) Financial Statements
Mobileye Global Inc. (MBLY) reported trailing twelve-month revenue of $2.0B (up 5.0% year on year) and net income of -$4.1B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $388.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MBLYMobileye Global Inc.Follow MBLY — free
—
Price chart with a free account
- Market cap
- 5.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 1.87 | 2.08 | 1.65 | 1.89 | 2.02 | |
| Gross profit | 0.92 | 1.05 | 0.74 | 0.90 | 0.96 | |
| Research & development | 0.79 | 0.89 | 1.08 | 1.15 | 1.12 | |
| Operating income | -0.04 | -0.03 | -3.23 | -0.44 | -4.18 | |
| Pre-tax income | -0.03 | 0.02 | -3.16 | -0.38 | -4.12 | |
| Income tax | 0.05 | 0.04 | -0.07 | 0.02 | -0.05 | |
| Net income | -0.08 | -0.03 | -3.09 | -0.39 | -4.06 | |
| Diluted EPS ($) | -0.11 | -0.03 | -3.82 | -0.48 | -4.98 | |
| Diluted shares (bn) | 0.759 | 0.805 | 0.809 | 0.813 | — |
USD billions · SEC XBRL
Mobileye Global Inc. — questions
- What is Mobileye Global Inc.'s revenue?
- $2.0B over the twelve months to 2026-06-30, up 5.0% year on year, from its 10-Q and 10-K filings.
- What is Mobileye Global Inc.'s net income?
- -$4.1B over the twelve months to 2026-06-30.
- What is Mobileye Global Inc.'s free cash flow?
- $388.0M over the twelve months to 2026-06-30.
- What are Mobileye Global Inc.'s diluted earnings per share?
- $-4.98 over the twelve months to 2026-06-30.
Every figure on this page comes from Mobileye Global Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.